Home LiteratureArticle Details
PMID: 12819898 Published · ppublish English Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies.

Diabetologia ·Vol. 46 ·No. 7 ·2003-07-00 ·Pages 990-5

Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP

Abstract

Several case-control studies have examined the association between the Gly972Arg variant in the IRS-1 gene and Type 2 diabetes, but most had limited power and results could therefore be conflicting. We systematically reviewed the literature by means of a meta-analysis and investigated sources of heterogeneity in results of different studies. The summary risk ratio, based on 3408 cases and 5419 control cases from 27 studies, was 1.25 (95% CI 1.05-1.48). The results, however, differed according to the type of study, method of verifying non-diabetic status of the control subjects, and age of the case subjects. Population-based studies reported lower odds ratios than hospital-based studies (OR 0.98, 95% CI 0.74-1.30 vs OR 1.43, 95% CI 1.17-1.74). Also, the diagnostic test to exclude diabetes amongst control subjects interacted with the association between the IRS-1 Gly972Arg variant and Type 2 diabetes (p=0.03). Finally, the odds ratio reduced with increasing age ( p=0.03). Overall, carriers of the 972Arg variant of the IRS-1 gene are at a 25% increased risk of having Type 2 diabetes compared with non-carriers. The odds ratios are generally higher in hospital-based studies, including relatively young, symptomatic, cases.

MeSH Terms
Amino Acid Substitution/genetics Arginine/genetics Diabetes Mellitus/genetics Diabetes Mellitus, Type 2/genetics Genetic Carrier Screening Genetic Variation/genetics Glycine/genetics Humans Insulin Receptor Substrate Proteins Obesity Odds Ratio Phosphoproteins/genetics Racial Groups/genetics
Chemicals
IRS1 protein, human Insulin Receptor Substrate Proteins Phosphoproteins Arginine Glycine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Jellema A
Centre for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. [email protected]
Zeegers M P A
Feskens E J M
Dagnelie P C
Mensink R P
References (51)
51 references, click to expand
  1. The mutation of insulin receptor substrate-1 gene in Chinese patients with non-insulin-dependent diabetes mellitus.
    Chin Med J (Engl). 2000 Jan;113(1):80-3 PMID: 11775217
  2. The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.
    J Clin Invest. 1999 Aug;104(3):357-64 PMID: 10430617
  3. Insulin sensitivity is not affected by mutation of codon 972 of the human IRS-1 gene.
    Horm Res. 1999;52(5):230-4 PMID: 10844412
  4. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus.
    J Clin Endocrinol Metab. 1994 Dec;79(6):1655-8 PMID: 7989470
  5. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.
    J Clin Invest. 1994 Sep;94(3):1141-6 PMID: 8083355
  6. Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes.
    Eur J Med Res. 2000 Nov 30;5(11):484-90 PMID: 11121369
  7. Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study.
    J Clin Endocrinol Metab. 1999 Mar;84(3):1002-6 PMID: 10084586
  8. Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis.
    Int J Epidemiol. 2001 Apr;30(2):353-62 PMID: 11369742
  9. Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus.
    Biochem Biophys Res Commun. 1994 Jul 15;202(1):463-9 PMID: 8037748
  10. Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families.
    Lancet. 1993 Dec 4;342(8884):1430 PMID: 7901717
  11. Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects.
    Hum Genet. 1997 Nov;101(1):118-9 PMID: 9385382
  12. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.
    Diabetologia. 2001 Mar;44(3):367-72 PMID: 11317670
  13. Amino acid polymorphisms of the insulin receptor substrate-1 in Japanese noninsulin-dependent diabetes mellitus.
    J Clin Endocrinol Metab. 1995 Sep;80(9):2822-6 PMID: 7673430
  14. Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.
    Diabetes Care. 1998 May;21(5):753-6 PMID: 9589236
  15. Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery.
    Diabetes Metab. 1998 Jun;24(3):244-50 PMID: 9690058
  16. Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM families.
    Diabet Med. 1996 Apr;13(4):341-5 PMID: 9162610
  17. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM.
    FASEB J. 1999 Dec;13(15):2173-8 PMID: 10593864
  18. A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q.
    Diabetes. 1999 Feb;48(2):398-402 PMID: 10334320
  19. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
    J Clin Invest. 1996 Jun 1;97(11):2569-75 PMID: 8647950
  20. Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1.
    Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1686-90 PMID: 9812905
  21. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions.
    Am J Epidemiol. 1999 Apr 15;149(8):706-11 PMID: 10206619
  22. Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography.
    Clin Lab Haematol. 1997 Jun;19(2):123-8 PMID: 9218152
  23. IRS-1 variant: A new risk factor for coronary artery disease?
    Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):283-4 PMID: 10669621
  24. Insulin signalling and the regulation of glucose and lipid metabolism.
    Nature. 2001 Dec 13;414(6865):799-806 PMID: 11742412
  25. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus.
    J Clin Endocrinol Metab. 1996 Apr;81(4):1657-9 PMID: 8636384
  26. Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism.
    Diabetes. 2002 May;51(5):1419-24 PMID: 11978638
  27. Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians.
    J Clin Endocrinol Metab. 1995 Sep;80(9):2827-9 PMID: 7673431
  28. Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitus.
    Diabet Med. 1996 Feb;13(2):133-8 PMID: 8641117
  29. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms.
    Diabetologia. 1996 May;39(5):600-8 PMID: 8739921
  30. Insulin receptor substrate-1 gene and cardiovascular risk factors in NIDDM.
    Lancet. 1995 Sep 23;346(8978):841-2 PMID: 7674763
  31. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
    Diabetologia. 1996 Dec;39(12 ):1505-11 PMID: 8960833
  32. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors.
    Exp Clin Endocrinol Diabetes. 2000;108(2):86-92 PMID: 10826514
  33. Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif.
    Diabetes. 1998 May;47(5):837-9 PMID: 9588458
  34. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.
    Lancet. 1995 Aug 12;346(8972):397-402 PMID: 7623569
  35. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.
    Lancet. 1993 Oct 2;342(8875):828-32 PMID: 8104271
  36. Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus.
    J Clin Endocrinol Metab. 1997 Dec;82(12):4201-7 PMID: 9398740
  37. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
    Nat Genet. 2000 Sep;26(1):76-80 PMID: 10973253
  38. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study.
    Diabetes. 1999 Sep;48(9):1868-72 PMID: 10480621
  39. Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.
    Diabetes. 1997 Jun;46(6):929-36 PMID: 9166661
  40. Bias in meta-analysis detected by a simple, graphical test.
    BMJ. 1997 Sep 13;315(7109):629-34 PMID: 9310563
  41. Genetic polymorphisms and disease.
    N Engl J Med. 1998 May 28;338(22):1626 PMID: 9606122
  42. No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population.
    Diabetes Care. 1996 May;19(5):446-9 PMID: 8732707
  43. A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease.
    Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2975-80 PMID: 10591678
  44. Cohort studies for characterizing measured genes.
    J Natl Cancer Inst Monogr. 1999;(26):39-42 PMID: 10854484
  45. Increased risk of diabetes in first-degree relatives of young-onset type 2 diabetic patients compared with relatives of those diagnosed later.
    Diabetes Care. 2002 Mar;25(3):636-7 PMID: 11874970
  46. Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease.
    Diabetologia. 1995 Apr;38(4):481-6 PMID: 7796990
  47. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias.
    J Natl Cancer Inst. 2000 Jul 19;92(14):1151-8 PMID: 10904088
  48. Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria.
    Diabetes Care. 1998 Aug;21(8):1266-70 PMID: 9702431
  49. Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans.
    Diabetes. 1996 May;45(5):563-8 PMID: 8621004
  50. Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes.
    Exp Clin Endocrinol Diabetes. 1999;107(5):318-22 PMID: 10482045
  51. Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.
    Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):370-7 PMID: 11025561
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
0012-186X
Published
2003-07-00
Epub
2003-00-18
Pages
990-5
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]